Jenny Tobin

900 total citations
14 papers, 551 citations indexed

About

Jenny Tobin is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jenny Tobin has authored 14 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jenny Tobin's work include Nitric Oxide and Endothelin Effects (6 papers), Gastrointestinal motility and disorders (4 papers) and Gastroesophageal reflux and treatments (3 papers). Jenny Tobin is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Gastrointestinal motility and disorders (4 papers) and Gastroesophageal reflux and treatments (3 papers). Jenny Tobin collaborates with scholars based in United States, Norway and United Kingdom. Jenny Tobin's co-authors include Mark G. Currie, Caroline B. Kurtz, Marco M. Kessler, Robert Solinga, Alexander P. Bryant, Gerhard Hannig, Robert Busby, Wilmin Bartolini, Shalina Mahajan‐Miklos and Christine M. Pierce and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Jenny Tobin

14 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Tobin United States 7 303 230 152 112 38 14 551
Wilmin Bartolini United States 9 348 1.1× 251 1.1× 154 1.0× 79 0.7× 32 0.8× 22 592
Hans Raskov Denmark 8 103 0.3× 49 0.2× 204 1.3× 64 0.6× 31 0.8× 9 461
James Wakefield United States 12 64 0.2× 79 0.3× 227 1.5× 236 2.1× 11 0.3× 26 626
Akima Miyoshi Japan 12 134 0.4× 206 0.9× 120 0.8× 47 0.4× 64 1.7× 47 473
Tetsuro Hiratsuka Japan 15 114 0.4× 214 0.9× 90 0.6× 44 0.4× 47 1.2× 26 474
Igor Nastaskin United States 8 160 0.5× 138 0.6× 118 0.8× 47 0.4× 51 1.3× 10 380
Toshiaki Nagano Japan 12 58 0.2× 96 0.4× 76 0.5× 78 0.7× 24 0.6× 24 426
Hirofumi Imoto Japan 15 48 0.2× 238 1.0× 148 1.0× 132 1.2× 65 1.7× 43 554
Motoyuki Moriga Japan 12 62 0.2× 197 0.9× 173 1.1× 67 0.6× 23 0.6× 51 494
Anne-Barbara Witte Sweden 7 80 0.3× 58 0.3× 177 1.2× 45 0.4× 17 0.4× 7 369

Countries citing papers authored by Jenny Tobin

Since Specialization
Citations

This map shows the geographic impact of Jenny Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Tobin more than expected).

Fields of papers citing papers by Jenny Tobin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Tobin. The network helps show where Jenny Tobin may publish in the future.

Co-authorship network of co-authors of Jenny Tobin

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Tobin. A scholar is included among the top collaborators of Jenny Tobin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Tobin. Jenny Tobin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rennie, Glen R., Timothy C. Barden, Sylvie G. Bernier, et al.. (2021). Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulator. Bioorganic & Medicinal Chemistry Letters. 40. 127886–127886. 4 indexed citations
2.
Liu, Guang, Sarah Jacobson, Sylvie G. Bernier, et al.. (2021). The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system. Journal of Neuroinflammation. 18(1). 213–213. 20 indexed citations
3.
Tang, Kim San, Sylvie G. Bernier, Jenny Tobin, et al.. (2021). The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases. Frontiers in Pharmacology. 12. 656561–656561. 26 indexed citations
4.
Wakefield, James, Timothy C. Barden, Jenny Tobin, et al.. (2020). Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of praliciguat, a clinical‐stage soluble guanylate cyclase stimulator in rats. Pharmacology Research & Perspectives. 8(2). e00579–e00579. 6 indexed citations
5.
Nakai, Takashi, Nicholas R. Perl, Timothy C. Barden, et al.. (2016). Discovery of IWP-051, a Novel Orally Bioavailable sGC Stimulator with Once-Daily Dosing Potential in Humans. ACS Medicinal Chemistry Letters. 7(5). 465–469. 24 indexed citations
6.
Tchernychev, Boris, Pei Ge, Marco M. Kessler, et al.. (2015). MRP4 Modulation of the Guanylate Cyclase-C/cGMP Pathway: Effects on Linaclotide-Induced Electrolyte Secretion and cGMP Efflux. Journal of Pharmacology and Experimental Therapeutics. 355(1). 48–56. 22 indexed citations
7.
Tobin, Jenny, Courtney Shea, Adaline C. Smith, et al.. (2015). Concomitant administration of sGC stimulators with common classes of anti-hypertensive agents results in increased efficacy in spontaneously hypertensive rats. BMC Pharmacology and Toxicology. 16(S1). 2 indexed citations
8.
Shea, Courtney, Sheila Ranganath, Guang Liu, et al.. (2015). IWP-121: a novel sGC stimulator that reduces blood pressure and exhibits anti-fibrotic and anti-inflammatory activities in the Dahl Salt-Sensitive rat model. BMC Pharmacology and Toxicology. 16(S1). 2 indexed citations
9.
Shea, Courtney, Sheila Ranganath, Guang Liu, et al.. (2015). sGC Stimulator Efficacy Beyond Blood Pressure in Dahl‐Salt Sensitive Model of Hypertension. The FASEB Journal. 29(S1). 2 indexed citations
10.
11.
Busby, Robert, Marco M. Kessler, Wilmin Bartolini, et al.. (2012). Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation. Journal of Pharmacology and Experimental Therapeutics. 344(1). 196–206. 112 indexed citations
12.
Busby, Robert, Alexander P. Bryant, Wilmin Bartolini, et al.. (2010). Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. European Journal of Pharmacology. 649(1-3). 328–335. 175 indexed citations
13.
Bryant, Alexander P., Robert Busby, Wilmin Bartolini, et al.. (2010). Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract. Life Sciences. 86(19-20). 760–765. 154 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilmin Bartolini Breakdown of academic impact, for papers by Hans Raskov Breakdown of academic impact, for papers by James Wakefield Breakdown of academic impact, for papers by Akima Miyoshi Breakdown of academic impact, for papers by Tetsuro Hiratsuka Breakdown of academic impact, for papers by Igor Nastaskin Breakdown of academic impact, for papers by Toshiaki Nagano Breakdown of academic impact, for papers by Hirofumi Imoto Breakdown of academic impact, for papers by Motoyuki Moriga Breakdown of academic impact, for papers by Anne-Barbara Witte
Rankless by CCL
2026